<DOC>
	<DOCNO>NCT02510677</DOCNO>
	<brief_summary>The prognosis patient heart failure improve due recent breakthrough medical treatment cardiac resynchronization device . However , paraclinical parameter ass response cardiac resynchronization therapy ( CRT ) . This major issue since third implanted patient improve CRT . CZT SPECT allow perform myocardial perfusion image less 4 minute able study myocardial perfusion , viability , leave ventricular function , also ventricular asynchrony . Using low-dose dobutamine gate SPECT CZT camera , aim ass leave ventricular dyssynchrony viable segment patient heart failure eligible CRT .</brief_summary>
	<brief_title>Three-dimensional Assessment Intraventricular Dyssynchrony Using Fast Dobutamine Gated SPECT</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>Patient heart failure optimal medical therapy target cardiac resynchronization therapy accord current recommendation ; Age 18 year Clinically stable ( without hospitalization heart failure last month ) Sinus rhythm Social security insurance Signed consent form Recent history ( le 21 day ) acute coronary syndrome unstable angina ; Recent history ( less 1 month ) acute heart failure ; Right bundle branch block ; Irregular heart rate ; Doublechamber cardiac pacemaker Patients previously implant singlechamber cardioverterdefibrillator must least 99 percent unstimulated QRS . Countraindication dobutamine therapy ; Valvular heart disease , congenital heart disease , hypertrophic cardiomyopathy ; Significant Ventricular arrhythmia ; Hypertension ( upper 160/100 mmHg ) ; Pregnant , breastfeed guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>